- Brainstorm Cell Therapeutics Inc Annual Shareholders Meeting TranscriptDec 18, 2023
- Q3 2023 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptNov 14, 2023€0.16 (+23.08%)Earnings
- Brainstorm Cell Therapeutics Inc Investor Call TranscriptOct 18, 2023
- Q2 2023 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptAug 14, 2023€1.45 (+1.40%)Earnings
- Q1 2023 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptMay 15, 2023€2.52 (-3.08%)Earnings
- Q4 2022 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptMar 30, 2023€2.2 (+39.05%)Earnings
- Brainstorm Cell Therapeutics Inc To Discuss The Company's Biologics License Application (BLA) for NurOwn(®) TranscriptMar 27, 2023
- Brainstorm Cell Therapeutics Inc Annual Shareholders Meeting TranscriptJan 10, 2023
- Brainstorm Cell Therapeutics Inc at EBD Group Biotech Showcase TranscriptJan 09, 2023
- Q3 2022 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptNov 14, 2022€1.4 (-7.92%)Earnings
- Brainstorm Cell Therapeutics Inc ALS One Research Symposium TranscriptOct 07, 2022
- Q2 2022 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptAug 15, 2022€3.57 (+26.70%)Earnings
- Q1 2022 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptMay 16, 2022€2.69 (+2.99%)Earnings
- Q4 2021 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptMar 28, 2022€3.04Earnings
- Q3 2021 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptNov 15, 2021€2.6Earnings
- Brainstorm Cell Therapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 12, 2021
- Q2 2021 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptAug 05, 2021€3.14 (+0.64%)Earnings
- Q1 2021 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptApr 26, 2021€2.82 (+4.44%)Earnings
- Q4 2020 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptFeb 04, 2021€5.15Earnings
- Brainstorm Cell Therapeutics Inc to Present at the Alliance for Regenerative Medicine TranscriptJan 08, 2021
- Q3 2020 Brainstorm Cell Therapeutics Inc Earnings and Corporate Update Call TranscriptOct 15, 2020
- Brainstorm Cell Therapeutics Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mesa (Virtual) TranscriptOct 12, 2020
- Q2 2020 Brainstorm Cell Therapeutics Inc Earnings and Corporate Update Call TranscriptAug 05, 2020
- Q1 2020 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptMay 07, 2020€6.15 (-7.52%)Earnings
- Q4 2019 Brainstorm Cell Therapeutics Inc Earnings Call TranscriptFeb 18, 2020€5.1 (+8.51%)Earnings
- Brainstorm Cell Therapeutics Inc at Noble Financial Emerging Growth Investor Conference TranscriptFeb 17, 2020
- Brainstorm Cell Therapeutics Inc at 3rd Annual NIF Forum TranscriptJan 17, 2020
- Brainstorm Cell Therapeutics Inc looks forward to top-line results for its ALS Phase 3 program TranscriptJan 15, 2020
- Brainstorm Cell Therapeutics Inc at Sachs Associates Neuroscience Innovation Forum TranscriptJan 12, 2020
Brainstorm Cell Therapeutics Inc To Discuss The Company's Biologics License Application (BLA) for NurOwn(®) Transcript
Greetings, and welcome to the BrainStorm Cell Therapeutics conference call. (Operator Instructions) As a reminder, this call is being recorded. And I would now like to introduce your host for today's call, Michael Wood of LifeSci Advisors. Mr. Wood, you may begin.
Good morning, and thank you for joining us. Earlier today, BrainStorm issued a press release announcing that the FDA will hold an Advisory Committee Meeting to review the company's Biologics License Application for NurOwn in the treatment of ALS. This announcement will be the topic of today's call.
Before passing it off to the company for prepared remarks, I would like to remind listeners that this conference call will contain numerous statements, descriptions, forecasts, and projections regarding BrainStorm Cell Therapeutics and its potential future business operations and performance, statements regarding the market potential for the treatment of neurodegenerative disorders such as ALS, the sufficiency of the company's existing capital resources for
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)